Change in Director / Key Managerial Personnel
Nature of change: Continuation of directorship beyond age limit
Name and DIN: Mr. Ashok Kumar Ramawat (DIN: 08818263)
Effective date and tenure: Continuation approved effective upon attaining age 75 on September 27, 2027. Approval obtained at 41st Annual General Meeting held on September 23, 2026.
Brief profile: Mr. Ramawat has completed Bachelors Degree in Science and possesses 46 years of post-qualification experience with good exposure in Pharmaceuticals Industry.
Confirmation of eligibility: Approval obtained pursuant to Regulation 17(1A) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Relationship with other directors: Mr. Ramawat is not related to any of the Directors or Key Managerial Personnel of the Company.
Previous KMP: The disclosure indicates continuation of existing directorship rather than replacement of a previous director.
Key Financial or Operational Approvals
Decisions taken: Shareholders approved the continuation of Mr. Ashok Kumar Ramawat as Non-Executive Independent Director notwithstanding attaining the age of 75 years. The approval was obtained with requisite majority.
Strategic or Business Context
No specific business outlook, risks, trends, or strategic developments were disclosed in this filing.
Any Other Material Information
Regulatory compliance: Disclosure made pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-PoD2/I/3762/2026 dated January 30, 2026.
Meeting details: The 41st Annual General Meeting commenced at 03:03 PM and concluded at 03:17 PM on September 23, 2026. The combined scrutinizer report was received on September 24, 2026.
Company details: Biofil Chemicals and Pharmaceuticals Limited (CIN: L24233MP1985PLC002709), Registered Office: B/12-B, Industrial Estate, Pologround, Indore-452015 (M.P.)
Scrip symbols: BSE Script Code: 524396; NSE Symbol: BIOFILCHEM; ISIN: INE829A01014